What's new

Human medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 26, Status: Authorised

Apr 16, 2025 - 15:05
 0
Human medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Countering DEI Retrenchment, Macy’s And AMP Beauty Partner To Spotlight Brands F...

Next Article

US AAFA submits letter of support for California AB 1362 bill

Related Posts

Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 31, 2025  0

Human medicines European public assessment report (EPAR): Awiqli, Insulin icodec, Date of authorisation: 17/05/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

Human medicines European public assessment report (EPAR): Trepulmix, treprostinil, Date of authorisation: 03/04/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 10, 2025  0